• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zota Health Care Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 69688.0
  • ISIN : INE358U01012
1,356.00 68 (5.30%)
  • As on 22 Sep 2026 (EOD)

  • Today’s Low

    1,295.00

  • Today’s High

    1,438.00

  • Open

    1,317.00

  • Perv Close

    1,287.80

  • 52W Low

    1,022.00

  • 52W High

    1,740.00

Key Indicators

  • P/E(TTM)

    191.53

  • Mar.Cap (₹Cr.)

    4,696.18

  • Div & Yield %

    0.07

  • Book Value(₹)

    256.46

  • Debt-Equity Ratio

    5.30

  • AGM Date

    22-Sep-2026

  • EPS

    7.08

  • P/E Ratio

    191.53

Financials Ratios

  • Debt-Equity Ratio

    0.82

  • Mar.Cap (₹Cr.)

    4,696.18

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    34.63

  • BV (₹)

    256.50

  • Sales( ₹ in Cr.)

    407.01

  • NP (in Cr.)

    28.60

  • NP Var(%)

    232.0

  • Div%

    10.0

  • CPS (₹)

    9.40

  • EPS (₹)

    8.30

  • Traded Value (₹ in Lakhs)

    4,696.18

  • 52 Week High

    1,740.00

  • 52 Week Low

    1,022.00

  • Price BSE

    0.0

  • Price NSE

    1,356.00

  • Market Capital( in Cr.)

    4,696.18

  • P/C Ratio

    144.30

  • P/E Ratio

    164.20

  • Price Vs.BV

    8.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 407.01 257.28 166.59 138.37 131.53 106.84
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 407.01 257.28 166.59 138.37 131.53 106.84
Other Income 13.40 4.62 2.05 3.10 1.65 2.29
Stock Adjustments 25.51 16.14 3.53 11.00 -1.48 2.14
Total Income 445.92 278.04 172.17 152.47 131.70 111.27
EXPENDITURE :            
Raw Materials 256.74 173.23 108.83 99.41 86.67 75.88
Power and Fuel Cost 1.07 1.13 0.97 0.73 0.84 0.70
Employee Cost 44.61 29.15 18.85 10.73 9.15 8.58
Other Manufacturing Expenses 3.96 3.23 2.00 0.93 1.43 1.55
Selling and Administration Expenses 94.26 54.79 33.11 29.40 16.54 21.43
Miscellaneous Expenses 1.30 0.44 0.12 0.16 0.07 0.16
Employee Benefit Expenses 44.61 29.15 18.85 10.73 9.15 8.58
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 401.95 261.98 163.89 141.35 114.70 108.30
Operating Profit 43.97 16.07 8.27 11.10 16.99 2.96
Interest 0.25 1.06 0.36 0.06 0.07 0.11
Gross Profit 43.72 15.01 7.91 11.04 16.92 2.85
Depreciation 3.95 3.17 3.01 2.42 2.73 3.17
Profit Before Tax 39.77 11.84 4.90 8.62 14.19 -0.32
Current Tax 10.84 3.36 1.47 2.05 3.69 0.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.01 -0.13 0.06 -0.02 -0.08 -0.17
Reported Net Profit 27.91 8.62 3.38 6.59 10.58 -0.16
Extraordinary Items -0.69 0.00 0.00 0.40 0.00 0.94
Adjusted Net Profit 28.60 8.62 3.38 6.19 10.58 -1.10
Adjustment below Net Profit -47.71 38.57 5.70 0.27 0.14 0.14
P & L Balance brought forward 74.49 30.05 23.55 20.46 12.26 14.74
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 3.06 2.74 2.58 3.77 2.52 2.46
P & L Balance carried down 51.62 74.49 30.05 23.55 20.46 12.26
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 10.00 15.00 10.00
Dividend Per Share(Rs) 1.00 1.00 1.00 1.00 1.50 1.00
Earnings Per Share-Unit Curr 8.06 3.01 1.31 2.62 4.21 -0.07
Earnings Per Share(Adj)-Unit Curr 8.06 3.01 1.31 2.62 4.21 -0.07
Book Value 256.46 110.83 47.11 37.54 36.32 27.02
Book Value(Adj)-Unit Curr 256.46 110.83 47.11 37.54 36.32 27.02

Shareholding Pattern

  • Promoter Group

    49.38%

  • Public Share Holding

    50.62%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 17,102,309 49.38 17,102,309 39
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 17,102,309 49.38 17,102,309 39
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,741,623 7.92 2,741,623 22
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 126,548 0.37 126,548 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,209,867 6.38 2,209,867 17
Trusts 40 0.00 40 2
Venture Capital Funds 0 0.00 0 0
Sub total 5,078,078 14.66 5,078,078 42
2] Non Institution
Bodies Corporate 640,896 1.85 640,896 142
Clearing Members 584,561 1.69 584,561 20
Directors of their Relatives 169,960 0.49 169,960 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 128,752 0.37 128,752 300
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 699,212 2.02 699,212 642
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,525,758 15.96 5,525,758 51
Individuals holding nominal share capital up to Rs. 1 lakh 4,240,077 12.24 4,219,242 13,390
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 86 0.00 0 1
Others 145,721 0.42 145,721 4
Sub Total 12,452,200 35.96 12,431,279 14,597
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 34,632,587 100.00 34,611,666 14,678

Company Background

Zota Health Care LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Zota Health Care Ltd
  • BSE Code : 69688.0
  • ISIN : INE358U01012

  • Incorporation Year

    2000

  • Registered Office

    Zota House 2/896 Hira Modi St
    Sagrampura, Surat,
    Gujarat-395002

  • Telephone

    91-261-2331601

  • FAX

    91-261-2346415

  • Chairman

    Ketankumar Zota

  • Managing Director

  • Company Secretary

    Ashvin Variya

  • Auditor

    Pradeep K Singhi & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Satellite Corporate Ser. P Ltd
    Unit-49 Bldg-13 AB ,
    Off Andheri Kurla Rd,MTNL Lane Sakinaka
    Mumbai - Mumbai-400072

Zota Health Care Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77